SMALL LYMPHOCYTIC LYMPPHO

Clinical trials for SMALL LYMPHOCYTIC LYMPPHO explained in plain language.

Never miss a new study

Get alerted when new SMALL LYMPHOCYTIC LYMPPHO trials appear

Sign up with your email to follow new studies for SMALL LYMPHOCYTIC LYMPPHO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a new pill outsmart Treatment-Resistant blood cancer?

Disease control Not yet recruiting

This phase III trial is testing whether an experimental drug called TQB3909 can help people with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) whose disease has returned or stopped responding to prior treatments. Participants will be randomly assigned to re…

Matched conditions: SMALL LYMPHOCYTIC LYMPPHO

Phase: PHASE3 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control

Last updated Aug 13, 2026 00:00 UTC

SMALL LYMPHOCYTIC LYMPPHO

Get alerted when new SMALL LYMPHOCYTIC LYMPPHO trials appear

Can a new pill outsmart Treatment-Resistant blood cancer?